BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 240 filers reported holding BLUEBIRD BIO INC in Q2 2015. The put-call ratio across all filers is 1.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $49,341,000 | -22.5% | 288,965 | -19.2% | 0.15% | -18.8% |
| Q4 2017 | $63,703,000 | +87.4% | 357,680 | +44.5% | 0.18% | +82.8% |
| Q3 2017 | $33,990,000 | +429.4% | 247,473 | +250.4% | 0.10% | +421.1% |
| Q1 2017 | $6,420,000 | -62.4% | 70,622 | -64.6% | 0.02% | -62.7% |
| Q3 2015 | $17,067,000 | -83.2% | 199,501 | -67.0% | 0.05% | -81.0% |
| Q2 2015 | $101,836,000 | +12.0% | 604,836 | -19.7% | 0.27% | +17.0% |
| Q1 2015 | $90,960,000 | +120.8% | 753,170 | +67.7% | 0.23% | +121.2% |
| Q4 2014 | $41,204,000 | +446.1% | 449,236 | +113.6% | 0.10% | +447.4% |
| Q3 2014 | $7,545,000 | -17.9% | 210,273 | -11.7% | 0.02% | +90.0% |
| Q2 2014 | $9,186,000 | – | 238,152 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,964,000 | $59,215,000 | 1.36% |
| Birchview Capital, LP | 75,500 | $2,276,000 | 1.35% |
| Camber Capital Management LP | 1,000,000 | $30,150,000 | 1.04% |
| Sessa Capital IM, L.P. | 875,000 | $26,381,000 | 1.02% |
| Bain Capital Life Sciences Investors, LLC | 538,179 | $16,226,000 | 0.92% |
| Tarsadia Capital, LLC | 100,000 | $3,015,000 | 0.81% |
| Bullseye Asset Management LLC | 67,872 | $2,046,000 | 0.76% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,304,246 | $39,323,000 | 0.58% |
| MANGROVE PARTNERS IM, LLC | 175,178 | $5,282,000 | 0.53% |
| Parametrica Management Ltd | 37,712 | $1,080,000 | 0.52% |